Bringing powerful CRISPR science into real-world solutions for better health
Our gene discovery program, rooted in advanced microbiome analysis, has led to the identification of novel Cas enzymes with unique and powerful properties.
These next-generation enzymes are engineered for superior specificity, minimal off-target effects, and adaptability across diverse applications – from ultra-sensitive detection of pathogens to targeted genome editing in complex tissues.
By building our own suite of proprietary Cas systems, we are shaping a sustainable foundation for the future – one that enhances freedom to operate, accelerates innovation, and enables transformative solutions across human and animal health.
Uncovering the Next Generation of CRISPR-Cas Enzymes
CRISPR-Cas Diagnostics with Lab-Quality Precision, Wherever Needed
Our CRISPR-Cas diagnostics deliver lab-quality precision at the point of care. Using our advanced Cas12 and Cas13 enzymes, the platform can detect both DNA and RNA from viruses, bacteria, and other pathogens with exceptional sensitivity—even enabling multiplex detection. By combining CRISPR’s molecular accuracy with smart assay design, it supports faster clinical decisions and rapid assay development for emerging threats in human and animal health. Fast, accurate, and affordable, our CRISPR diagnostics bridge the gap between scientific precision and real-world usability.
Targeting Degenerative Eye Diseases at Its Source
Our gene therapy platform offers a transformative approach to treating degenerative eye diseases by addressing the underlying causes of vision loss, rather than merely managing symptoms.
Building on this foundation, our smart nanodelivery system enables precise transport of CRISPR-Cas and other gene-editing tools directly to the affected cells, minimizing off-target effects and enhancing treatment accuracy.
Beyond gene therapy, our nanotechnology also supports targeted drug delivery, including the development of a simple, effective eye-drop formulation, providing a versatile and patient-friendly solution to preserve and restore sight.
Our Technologies
Where Therapeutics, Diagnostics & Discovery Converge
-
Our discovery platform advances the identification of novel Cas enzymes with high thermostability, robust room-temperature activity, and flexible probe compatibility, enabling ultra-sensitive molecular diagnostics and efficient multiplexed detection.
-
We develop CRISPR-Cas diagnostic assays with optimized reaction conditions and lab-level sensitivity and specificity, integrated into portable point-of-care devices that provide rapid, accurate detection of pathogens and genetic targets anywhere
-
Our smart nanodelivery system enables precise, targeted transport of CRISPR-Cas, gene-editing tools, and therapeutics, minimizing off-target effects and supporting versatile, patient-friendly treatments, including innovative eye-drop formulations